Sigma Healthcare: Half Yearly Reports & Accounts
Filed with ASX · · 23 pages · English
Summary by 6ix AI
The report highlights a decrease in net profit after tax attributable to owners, which fell sharply due to one-off costs related to a merger proposal and upfront costs for a new supply contract. Despite these challenges, the company reported an increase in sales revenue, reflecting growth in its core wholesaling business and the benefits of a new supply contract. An interim dividend has been declared, although it is unfranked and not reflected in the balance sheet as of the reporting date.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Sigma Healthcare
- Half Year Results
- Sigma Acknowledges ACCC Announcement
- Boral Limited to be removed from the S&P/ASX 200 Index
- Sigma Full Year 2023/24 Results Presentation
- Sigma Full Year 2023/24 ASX Release
Later from Sigma Healthcare
- Half Year Results Presentation
- Sigma welcomes the ACCC's decision
- Chemist Warehouse Scheme Meeting and Scheme Booklet
- Sigma Notice of Meeting
- Sigma - Draft Prospectus
Follow Sigma Healthcare into a list and get an email when it puts out news.
Follow Sigma Healthcare